FDA approves Tonix’ Phase 2 Trial of TNX-2900 for Prader-Willi Syndrome
The FDA has cleared Tonix Pharmaceuticals’ Investigational New Drug (IND) application to support clinical development of TNX-2900...
top of page
Browse by category
Search
Browse by tag
bottom of page